Coagulation analyzer & reagents - FSS contract - V797D-60637

Active Awarded Last action

Contract number
W81K0022F0160
Awardee
Awarding agency
Obligated
$1,076,127

Award facts

Opportunity
  • W81K0022Q0202 Solicitation number
Contract value 80% obligated
  • $1,269,392.02 Current, with exercised options
  • $1,337,356.78 Potential, with all options
Completion date 81% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00014 · Pursuant to federal acquisition regulation (far) 52.217-9, option to extend the term of the contract, W81K00-22-f-0160 with ortho clinical diagnostics, INC.,… $0
Supplemental Agreement for work within scope P00013 · The purpose of this bilateral modification is to add MTS anti-c (monoclonal) cards 1X20 and MTS anti-e (monoclonal) cards 1X20 to the existing ortho vision… $5,294
Other Administrative Action P00012 $0
Funding Only Action P00011 · In accordance with federal acquisition regulation (far) 52.232-18, availability of funds, FY26 funds are available and hereby obligated for delivery order… $255,936
Exercise an Option P00010 · Pursuant to federal acquisition regulation (far) 52.217-9, option to extend the term of the contract, W81K00-22-f-0160 with ortho clinical diagnostics, INC.,… $0
Other Administrative Action P00009 · MTS a/b/d mono & reverse GRP c $0
Supplemental Agreement for work within scope P00008 · MTS a/b/d mono & reverse GRP c - decrease & add new reagent. $5,250
Funding Only Action P00007 · MTS a/b/d mono & reverse GRP c - FY25 funding modification $267,436
Exercise an Option P00006 · MTS a/b/d mono & reverse GRP c - FY25 option year $0
Supplemental Agreement for work within scope P00005 · MTS a/b/d mono & reverse GRP c - add & decrease of quantities for reagents. $0
Funding Only Action P00004 · MTS a/b/d mono & reverse GRP c - funding modification $271,106
Exercise an Option P00003 · MTS a/b/d mono & reverse GRP c - exercise the FY24 option year. $0
Supplemental Agreement for work within scope P00002 · MTS a/b/d mono & reverse GRP c - add immunohematology testing reagents. $64,685
Funding Only Action P00001 · MTS a/b/d mono & reverse GRP c - FY23 funding action $206,420
Original award $0
Show all 15

About this award

The Defense Health Agency extended a delivery order to Quidelortho Sales Company, LLC on October 1, 2022, for coagulation analyzer and reagents under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule, with a ceiling value of $1.34 million. The extension covers Option Year 4, running from October 1, 2026 through September 30, 2027.

Quidelortho Sales Company is a HUBZone joint venture. Place of performance is Fort Sam Houston, TX. Pricing is firm fixed price with no set-aside used.

Quick answers

Who was awarded contract W81K0022F0160?

W81K0022F0160 was awarded to Quidelortho Sales Company, LLC by Medical Command (Department of the Army) on October 1, 2022.

How much is contract W81K0022F0160 worth?

The government has obligated $1,076,127 on W81K0022F0160. Its current value, with exercised options, is $1,269,392. Its potential value, with all options, is $1,337,357.

Which agency awarded contract W81K0022F0160?

Medical Command (Department of the Army) awarded W81K0022F0160, with funding from Defense Health Agency (Department of Defense).

Is contract W81K0022F0160 an order under another contract?

Yes. W81K0022F0160 is a delivery order under V797D60637, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract W81K0022F0160 competed?

The extent of competition for W81K0022F0160 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award